CMI Parameter at 1 y | Low-Responders at 1 y (n = 16) | High-Responders at 1 y (n = 57) | p Value | Nonresponders at 2 y (n = 15) | Low- Responders at 2 y (n = 28) | High-Responders at 2 y (n = 29) | p Value |
---|---|---|---|---|---|---|---|
IFN-γ secretion (pg/ml), median (IQR) | 18.64 (32.18) | 24.23 (30.98) | 0.119 | 22 (37.84) | 17.15 (34.26) | 33.16 (44.87) | 0.025 (0.009a) |
IL-10 secretion (pg/ml), median (IQR) | 32.11 (87.17) | 82.32 (163.16) | 0.05 | 35.09 (114.69) | 79.87 (162.62) | 79.06 (119.45) | 0.112 (0.05b, 0.069c) |
IL-13 secretion (pg/ml), median (IQR) | 529.61 (1219.63) | 978.30 (957.53) | 0.125 | 796.25 (1104.05) | 1157.21 (1313.74) | 860.19 (988.54) | 0.262 |
TNF-α secretion (pg/ml), median (IQR) | 103.50 (131.24) | 171.24 (209.45) | 0.06 | 116.11 (161) | 178.65 (231.64) | 162.27 (175.13) | 0.115 (0.032c) |
Nonresponders: anti-HBs levels <10 IU/l; low-responders: anti-HBs levels 10–100 IU/l; high-responders: anti-HBs levels ≥100 IU/l. Categorical data are presented as a number (%). The bold text indicates statistical significance.
a Low-responders versus high-responders.
b Nonresponders versus low-responders.
c Nonresponders versus high-responders.